Best Telehealth Clinics in New York (2026)

New York has some of the strictest telehealth prescribing rules in the country. The core statute is NY Public Health Law Article 29-G (Sections 2999-cc through 2999-ee), which defines telehealth modalities and reimbursement requirements. Audio-only telehealth was added permanently to the definition by Senate Bill S8416 in 2020.

The state finalized 10 NYCRR § 80.63 on May 21, 2025. This regulation directly addresses controlled substance prescribing via telemedicine and states that no controlled substance shall be prescribed prior to an in-person medical evaluation. Exceptions include: a consulting provider who performed an in-person evaluation for the same condition within 12 months, temporary coverage by a covering provider with adequate communication with the initial prescriber, and emergency situations with specified safeguards. The rule also incorporates the federal DEA waiver as an exception.

The federal DEA waiver extends through December 31, 2026, suspending the Ryan Haight Act in-person requirement for Schedule II through V substances. While this waiver is active, NY providers can prescribe testosterone and other controlled substances via telehealth without an in-person visit. Once the federal extension expires, New York's codified rule under § 80.63 will require an in-person evaluation before any controlled substance telehealth prescription. This is a material risk for patients who start TRT via telehealth in New York.

Payment parity (insurers must reimburse telehealth at the same rate as in-person) is codified in NY Insurance Law § 3217-h and § 4306-g, but these provisions have a recurring sunset clause. The current extension runs through April 1, 2026. Senate Bill S2776/S2776A has attempted to eliminate the sunset, but has not passed. A 2022 budget amendment tightened the definition of distant site: providers must be located in the United States or its territories.

New York is not a member of the Interstate Medical Licensure Compact. Physicians treating NY patients must hold a current New York license through the NY Office of the Professions. Active legislation (A.1983/S.5657) would add NY to the IMLC, but has not passed as of April 2026. This makes New York one of the most difficult states for telehealth providers to enter, alongside California.

Additional requirements: mandatory electronic prescribing (EPCS) for all controlled substances. Nurse practitioners require a collaborative physician agreement under NY Education Law § 6902 unless they have 3,600+ hours of qualifying experience under the Nurse Practitioner Modernization Act. No physician may have more than four NP collaborators who are not co-located with that physician. Physician assistants require a written supervisory agreement.

Despite being the fourth-largest state by population (20.2 million), New York's strict regulations reduce the provider pool compared to Texas or Florida. Of the 64 providers tracked, roughly 50 to 55 serve New York. The two main limiting factors are the lack of IMLC membership (requiring a separate NY license) and the codified in-person requirement for controlled substances that will take effect when the federal DEA waiver expires.

Most major TRT providers serve New York. Maximus ($100/mo with labs, all 50 states), Hone Health ($25/mo entry, all 50 states), and providers listing "Most US states" like BraverX ($129/mo with labs), PeterMD ($99/mo annual with labs), DudeMeds ($77/mo), Titan Medical ($99/mo), and Male Excel ($99/mo) are available. TRT Nation ($99/mo) excludes only five states (AL, AK, AR, MO, HI), so New York is covered. Feel30 excludes many states and may not serve New York for TRT, though their enclomiphene service covers all 50.

GLP-1 availability is good despite the regulatory complexity. Embody ($99/mo), SkinnyRx ($99/mo), Remedy Meds ($179/mo), DirectMeds ($199/mo), GobyMeds ($119/mo), and Sesame Care all serve all 50 states. CareBare and Novi serve "Most US states" and likely include NY. MEDVi, Shed, Sunlight, and Mochi Health also cover all 50 states.

HRT coverage is full. All eight providers on our list serve New York, including insurance-accepting options Midi Health and PlushCare. Hone Health covers all 50 states for women's HRT. Alloy, Winona, Evernow, and Gennev serve "Most US states" and include NY.

Hair loss and ED providers have universal coverage in New York. Hims, Keeps, Ro, BlueChew, and Happy Head all serve all 50 states or "Most US states" with NY included. The main gap is in peptides: Limitless TRT operates in "select states" and likely excludes NY. Enhance MD may also exclude the state.

TRT costs in New York track national averages. The providers and pricing available are the same as most other large states since telehealth is priced nationally. Here is the breakdown:

DudeMeds: $77/mo (labs $200 extra, true annual $1,124). TRT Nation: $99/mo (labs $258 extra, true annual $1,446). PeterMD: $99/mo annual (labs included, true annual $1,188, requires upfront payment). Maximus: $100/mo annual (labs included, AI coaching, true annual $1,300). Titan Medical: $99/mo (labs $229 extra, true annual $1,417). BraverX: $129/mo (labs included, no contract, true annual $1,548). Henry Meds: $129/mo (labs included, true annual $1,548). Blokes: $149/mo (labs included, true annual $1,788). Defy Medical: $200/mo (labs included, true annual $2,800). Marek Health: $166/mo (labs $700 extra, true annual $2,692).

New York does not tax prescription medications. Telehealth consultations are not subject to state sales tax. New York City residents face higher general living costs, but telehealth pricing is set nationally, so the per-visit cost is the same as other states.

GLP-1 pricing matches the national range. Entry-level at $99/mo (Embody, SkinnyRx, Zealthy). GobyMeds is $119/mo. Fridays is $117/mo with coaching included. Most mid-tier options are $179/mo. TrimRx is the most expensive at $399/mo. MEDVi is $179/mo first month but $299/mo ongoing.

New York Medicaid does not cover GLP-1 medications for weight loss as of April 2026. Governor Hochul directed the Department of Health in January 2025 to evaluate GLP-1 access for Medicaid members at high cardiovascular risk, but that evaluation is still ongoing with no coverage announced. GLP-1s for type 2 diabetes remain covered. The federal BALANCE Model (CMS) could expand coverage starting May 2026, but NY has not confirmed participation.

HRT costs: Midi Health bills insurance directly (free for covered patients). PlushCare is $20/mo membership with insurance billing. Cash-pay: Evernow $35/mo, Alloy $49/mo, Winona $99/mo, Gennev $99/mo, Hone $25/mo entry tier to $149/mo premium. ED: Hims $17/mo, BlueChew $20/mo, Ro $23/mo, Keeps $25/mo.

TRT (testosterone replacement therapy)

New York codified an in-person evaluation requirement for controlled substance prescribing under 10 NYCRR § 80.63, finalized May 21, 2025. The federal DEA waiver currently suspends this requirement through December 2026, allowing telehealth TRT prescribing without an in-person visit. Once the waiver expires, New York patients will likely need an in-person evaluation before starting TRT online. Both compounded and FDA-approved testosterone are available. Electronic prescribing is mandatory for all controlled substances in NY. Prescribers must check the Prescription Monitoring Program. Delivery methods include injection, cream, oral, and enclomiphene.

GLP-1 weight loss

No state-specific restrictions on semaglutide or tirzepatide in New York. Federal FDA rules govern compounded availability. Tirzepatide remained on the FDA shortage list longer than semaglutide, so compounded tirzepatide may still be more accessible than compounded semaglutide. New York has no additional compounding restrictions beyond the federal framework. The FDA issued over 55 warning letters to online sellers of compounded GLP-1 medications in September 2025.

HRT (hormone replacement therapy)

HRT follows standard federal prescribing rules in New York. No additional state restrictions apply. All eight HRT telehealth providers on our list serve the state. Insurance coverage through Midi Health and PlushCare is available for qualifying patients.

Hair loss

Hair loss treatment follows standard federal prescribing rules in New York. No additional state restrictions apply. All providers serve NY.

ED (erectile dysfunction)

ED treatment follows standard federal prescribing rules in New York. No additional state restrictions apply. Generic sildenafil, tadalafil, and compounded formulas are all available through telehealth.

Peptides

Peptide therapy follows standard federal rules in New York. No state-specific bans on sermorelin, BPC-157, or NAD+ were found. The main barrier is provider availability. New York's licensing requirements and lack of IMLC membership limit the number of telehealth peptide providers operating in the state. Maximus (all 50 states) and Defy Medical ("Most US states") are the most reliably available peptide providers in NY.